Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

<p>Supplementary Table S4. Mutations status of patients with disease progression on BTKis</p>

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Anfal Alsadhan (15907475) (author)
Eará dahkkit: Jonathan Chen (15907478) (author), Erika M. Gaglione (15032498) (author), Chingiz Underbayev (15907481) (author), Pamela L. Tuma (15907484) (author), Xin Tian (15907487) (author), Lita A. Freeman (15907490) (author), Sivasubramanian Baskar (15907493) (author), Pia Nierman (15907496) (author), Susan Soto (15907499) (author), Andy Itsara (15907502) (author), Inhye E. Ahn (15032501) (author), Clare Sun (14953020) (author), Elena Bibikova (15907505) (author), Tanja Nicole Hartmann (15907508) (author), Maissa Mhibik (15907511) (author), Adrian Wiestner (15907514) (author)
Almmustuhtton: 2025
Fáttát:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Lasit vuosttaš kommeantta. Visot kommeanttat leat almmolaččat.!
Čálihuva vuohččan sisa

Geahča maid